Notice2023-15038
Healthcare Infection Control Practices Advisory Committee (HICPAC)
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
July 17, 2023
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
In accordance with regulatory provisions, the Centers for Disease Control and Prevention (CDC) announces the following meeting of the Healthcare Infection Control Practices Advisory Committee (HICPAC). This is a virtual meeting. The public is welcomed to listen to the meeting via Zoom; 500 teleconference lines are available. Time will be available for public comment. Registration is required.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 135 (Monday, July 17, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 135 (Monday, July 17, 2023)]
[Notices]
[Pages 45426-45427]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-15038]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Healthcare Infection Control Practices Advisory Committee
(HICPAC)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with regulatory provisions, the Centers for
Disease Control and Prevention (CDC) announces the following meeting of
the Healthcare Infection Control Practices Advisory Committee (HICPAC).
This is a virtual meeting. The public is welcomed to listen to the
meeting via Zoom; 500 teleconference lines are available. Time will be
available for public comment. Registration is required.
DATES: The meeting will be held on August 22, 2023, from 12 p.m. to
2:30 p.m., EDT.
ADDRESSES: To register for this web conference, please go to:
<a href="http://www.cdc.gov/hicpac">www.cdc.gov/hicpac</a>. All registered participants will receive the
meeting link and instructions shortly before the meeting. Please click
the link below to join the webinar: <a href="https://cdc.zoomgov.com/j/1615322622?pwd=T1Vnci9IQVF6YS9nQzBzTTlTZTQzZz09">https://cdc.zoomgov.com/j/1615322622?pwd=T1Vnci9IQVF6YS9nQzBzTTlTZTQzZz09</a>.
Meeting ID: 161 532 2622
Passcode: 36073986
FOR FURTHER INFORMATION CONTACT: Sydnee Byrd, M.P.A., HICPAC, Division
of Healthcare Quality Promotion (DHQP), National Center for Emerging
and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control
and Prevention, l600 Clifton Road NE, Mailstop H16-3, Atlanta, Georgia
30329. Telephone (404) 718-8039; Email: <a href="/cdn-cgi/l/email-protection#0b6362687b6a684b686f68256c647d"><span class="__cf_email__" data-cfemail="96fefff5e6f7f5d6f5f2f5b8f1f9e0">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION:
Purpose: The Committee is charged with providing advice and
guidance to the Director, DHQP; the Director, NCEZID; the Director,
CDC; and the Secretary, Department of Health and Human Services,
regarding (1) the practice of healthcare infection prevention and
control; (2) strategies for surveillance, prevention, and control of
infections, antimicrobial resistance, and related events in settings
where healthcare is provided; and (3) periodic updating of CDC
guidelines and other policy statements regarding prevention of
healthcare-associated infections and healthcare-related conditions.
Matters to be Considered: The agenda will include the following
updates: The Healthcare Personnel Guideline Workgroup; Isolation
Precautions Guideline Workgroup; National Healthcare Safety Network
Workgroup; and Dental Unit Waterlines Guideline Update. Agenda items
are subject to change as priorities dictate.
Public Participation
Oral Public Comment: Time will be available for public comment.
Members of the public who wish to provide public comments should plan
to attend the public comment session at the start time listed. Please
note that the public comment period may end before the time indicated,
following the last call for comments.
Written Public Comment: The public may submit written comments in
advance of the meeting. Comments should be submitted in writing by
email to the contact person listed above. The deadline for receipt of
written public comment is August 25, 2023. All
[[Page 45427]]
requests must contain the submitter's name, address, and organizational
affiliation, as well as the topic being addressed. Written comments
should not exceed one single-spaced typed page in length and delivered
in 3 minutes or less. Written comments received in advance of the
meeting will be included in the official record of the meeting.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-15038 Filed 7-14-23; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on July 17, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.